AstraZeneca
Senior Scientist – Crystallisation at AstraZeneca within Early Chemical Development responsible for delivering drug substance physical attributes and particle properties for clinical programs up to Phase II. The role is laboratory-based at the Macclesfield campus and focuses on solid form and particle property development. It involves close collaboration with internal development teams and external CDMOs to support development and GMP manufacture.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
AstraZeneca didn’t post a salary, so this is our estimate from similar listings.
Materials Science Lead
Pfizer
Protein Crystallisation Specialist
The University of Melbourne
Scientist/Senior Scientist – Crystallisation & Solid State
Catsci Ltd
Particle Engineering Scientist
Eurofins
Section Lead Particle Design
Roche
(Senior) Scientist in Precipitation & Particle Design (temp role)
Johnson & Johnson Medical Korea Limited